Back to today’s briefing

Story perspectives

UK Approves Groundbreaking Drug to Delay Type 1 Diabetes

8/15/2025

49 6

Summary

Story summary

The UK has approved Teplizumab, the first drug to delay type 1 diabetes onset in those aged eight and older.
Experts consider this a significant breakthrough, potentially delaying the disease by up to three years.
NHS funding for the drug is under consideration; eligible patients may access it privately.
Around 400,000 individuals in the UK are affected by type 1 diabetes.

1 of 1

Story summary

The UK has approved Teplizumab, the first drug to delay type 1 diabetes onset in those aged eight and older.
Experts consider this a significant breakthrough, potentially delaying the disease by up to three years.
NHS funding for the drug is under consideration; eligible patients may access it privately.
Around 400,000 individuals in the UK are affected by type 1 diabetes.